AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351 (k) biosimilar pathway, today announced that ...

AEON Biopharma, Inc. (AEON ... regulatory pathway offers potential to bring ABP-450 to the U.S. market under a single approval for all of BOTOX’s currently approved and future therapeutic ...

The spotlight on refrigerant leak detection, monitoring and reporting has never been brighter as the HVAC and refrigeration ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

This move is expected to inject new dynamism into the market, fostering a more robust investment environment and potentially ...

Yesterday, the Honourable Lawrence MacAulay, federal Minister of Agriculture and Agri-Food, convened provincial and territorial Ministers of Agriculture to discuss several key areas of interest for ...

Planned development on the west end of Rochester's planned Link Bus Rapid Transit system is expected to generate at least $40 ...

ALAIA Titiwangsa, a premium serviced apartment development in Taman Tiara Titiwangsa, is set to be relaunched under the ...